Pilocarpine Hydrochloride Patent Expiration
Pilocarpine Hydrochloride is Used for correcting age-related loss of near vision (presbyopia). It was first introduced by Alcon Laboratories Inc
Pilocarpine Hydrochloride Patents
Given below is the list of patents protecting Pilocarpine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Vuity | US10610518 | Presbyopia treatments | Apr 24, 2039 | Abbvie |
| Vuity | US11285134 | Presbyopia treatments | Apr 24, 2039 | Abbvie |
| Qlosi | US10639297 | Ophthalmic pharmaceutical compositions and uses relating thereto | Aug 18, 2037 | Orasis Pharms |
| Qlosi | US11129812 | Ophthalmic pharmaceutical compositions and uses relating thereto | Aug 18, 2037 | Orasis Pharms |
| Qlosi | US11974986 | Ophthalmic pharmaceutical compositions and uses relating thereto | Aug 18, 2037 | Orasis Pharms |
| Qlosi | US9867810 | Ophthalmic pharmaceutical compositions and uses relating thereto | Aug 18, 2037 | Orasis Pharms |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Pilocarpine Hydrochloride's patents.
Latest Legal Activities on Pilocarpine Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Pilocarpine Hydrochloride.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 25 Oct, 2023 | US10639297 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Sep, 2023 | US10610518 |
| Patent Issue Date Used in PTA Calculation Critical
| 29 Mar, 2022 | US11285134 |
| Recordation of Patent Grant Mailed Critical
| 29 Mar, 2022 | US11285134 |
| Email Notification Critical
| 10 Mar, 2022 | US11285134 |
| Issue Notification Mailed Critical
| 09 Mar, 2022 | US11285134 |
| Dispatch to FDC | 01 Mar, 2022 | US11285134 |
| Mail Post Card | 23 Feb, 2022 | US11285134 |
| Issue Fee Payment Received Critical
| 17 Feb, 2022 | US11285134 |
| Issue Fee Payment Verified Critical
| 17 Feb, 2022 | US11285134 |
Pilocarpine Hydrochloride's Family Patents
